Satellos Operating Income from 2010 to 2026
| MSCL Stock | 0.81 0.03 3.57% |
Operating Income | First Reported 2010-12-31 | Previous Quarter -25 M | Current Value -23.8 M | Quarterly Volatility 9.3 M |
Check Satellos Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Satellos Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Selling General Administrative of 9.9 M or Selling And Marketing Expenses of 338.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.81. Satellos financial statements analysis is a perfect complement when working with Satellos Bioscience Valuation or Volatility modules.
Satellos | Operating Income |
Latest Satellos Bioscience's Operating Income Growth Pattern
Below is the plot of the Operating Income of Satellos Bioscience over the last few years. Operating Income is the amount of profit realized from Satellos Bioscience operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Satellos Bioscience is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Satellos Bioscience's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Satellos Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Satellos Operating Income Regression Statistics
| Arithmetic Mean | (7,457,641) | |
| Coefficient Of Variation | (125.18) | |
| Mean Deviation | 7,436,921 | |
| Median | (1,999,541) | |
| Standard Deviation | 9,335,427 | |
| Sample Variance | 87.2T | |
| Range | 26.3M | |
| R-Value | (0.78) | |
| Mean Square Error | 36T | |
| R-Squared | 0.61 | |
| Significance | 0.0002 | |
| Slope | (1,447,525) | |
| Total Sum of Squares | 1394.4T |
Satellos Operating Income History
About Satellos Bioscience Financial Statements
Satellos Bioscience investors utilize fundamental indicators, such as Operating Income, to predict how Satellos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -25 M | -23.8 M |
Pair Trading with Satellos Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against Satellos Stock
| 0.53 | APS | Aptose Biosciences | PairCorr |
| 0.49 | CM | Canadian Imperial Bank | PairCorr |
| 0.4 | RY | Royal Bank | PairCorr |
| 0.4 | AX-UN | Artis Real Estate | PairCorr |
| 0.36 | BRK | Berkshire Hathaway CDR | PairCorr |
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.